EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Precise modulation and use of reactive oxygen species for immunotherapy

Xinyan Li iD, Jingjing Gao iD, Chengcheng Wu iD, Chaoyu Wang, Ruoshi Zhang, Jia He iD, Ziting Judy Xia iD, Nitin Joshi iD, Jeffrey M Karp iD, Rui Kuai iD

Science Advances · 17.05.2024 · 10 (20)

DOI: 10.1126/sciadv.adl0479 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 17.05.2024. Verfasst von Xinyan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Immunotherapy. Die Arbeit wurde bisher 135-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactive oxygen species (ROS) play an important role in regulating the immune system by affecting pathogens, cancer cells, and immune cells. Recent advances in biomaterials have leveraged this mechanism to precisely modulate ROS levels in target tissues for improving the effectiveness of immunotherapies in infectious diseases, cancer, and autoimmune diseases. Moreover, ROS-responsive biomaterials can trigger the release of immunotherapeutics and provide tunable release kinetics, which can further boost their efficacy. This review will discuss the latest biomaterial-based approaches for both precise modulation of ROS levels and using ROS as a stimulus to control the release kinetics of immunotherapeutics. Finally, we will discuss the existing challenges and potential solutions for clinical translation of ROS-modulating and ROS-responsive approaches for immunotherapy, and provide an outlook for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesImmunotherapyHumansAnimalsNeoplasmsBiocompatible Materials

Substanzen

Reactive Oxygen SpeciesBiocompatible Materials

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
  • Tsinghua-Peking Center for Life Sciences, Beijing 100084, China.
  • Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Biomedical Engineering, Material Science and Engineering Graduate Program and The Center for Bioactive Delivery-Institute for Applied Life Sciences, University of Massachusetts, Amherst, MA 01003, USA.

ORCID-Profile: Xinyan Li, Jingjing Gao, Chengcheng Wu, Jia He, Ziting Judy Xia, Nitin Joshi, Jeffrey M Karp, Rui Kuai

Förderung

  • NIAMS NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Li, X., Gao, J., Wu, C., Wang, C., Zhang, R., He, J., Xia, Z. J., Joshi, N., Karp, J. M., & Kuai, R. (2024). Precise modulation and use of reactive oxygen species for immunotherapy. Science Advances, 10(20). https://doi.org/10.1126/sciadv.adl0479

Vancouver

Li X, Gao J, Wu C, Wang C, Zhang R, He J, et al. Precise modulation and use of reactive oxygen species for immunotherapy. Science Advances. 2024;10(20). doi:10.1126/sciadv.adl0479

BibTeX
@article{Li2024,
  author = {Li, Xinyan and Gao, Jingjing and Wu, Chengcheng and Wang, Chaoyu and Zhang, Ruoshi and He, Jia and Xia, Ziting Judy and Joshi, Nitin and Karp, Jeffrey M and Kuai, Rui},
  title = {Precise modulation and use of reactive oxygen species for immunotherapy},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {20},
  doi = {10.1126/sciadv.adl0479}
}
Kostenlos starten →